{
    "name": "tobramycin ophthalmic",
    "comment": "Rx",
    "other_names": [
        "Tobrex",
        "Tobramycin Ophth",
        "AKTob"
    ],
    "classes": [
        "Aminoglycosides",
        "Ophthalmic"
    ],
    "source": "https://reference.medscape.com/drug/tobrex-tobramycin-ophthalmic-343586",
    "pregnancy": {
        "common": [
            "Reproduction studies in three types of animals at doses up to thirty-three times normal human systemic dose have revealed no evidence of impaired fertility or harm to the fetus due to drug; there are, however, no adequate and well-controlled studies in pregnant women; because animal studies are not always predictive of human response, drug should be used during pregnancy only if clearly needed"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Because of potential for adverse reactions in nursing infants, a decision should be made whether to discontinue nursing infant or discontinue drug, taking into account importance of drug to mother"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to aminoglycosides or any component of formulation"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Sensitivity to topically administered aminoglycosides may occur; severity may vary from local effects to generalized reactions; discontinue use if sensitivity reactions occur",
                "Monitor serum aminoglycoside concentrations if concurrent systemic aminoglycoside therapy is in progress",
                "Concurrency with topical corticosteroids after uncomplicated removal of corneal foreign body; such concurrency may mask clinical signs of bacterial/fungal/viral infections",
                "May result in overgrowth of nonsusceptible organisms, including fungi",
                "Not for injection into eye"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Localized ocular toxicity and hypersensitivity",
            "percent": "3"
        },
        {
            "name": "including increased lacrimation",
            "percent": null
        },
        {
            "name": "itching and edema of eyelid",
            "percent": null
        },
        {
            "name": "and conjunctival erythema",
            "percent": null
        },
        {
            "name": "Sensitivity reaction",
            "percent": null
        },
        {
            "name": "punctate keratitis",
            "percent": null
        },
        {
            "name": "Anaphylactic reaction",
            "percent": null
        },
        {
            "name": "Erythema multiforme",
            "percent": null
        },
        {
            "name": "Stevens",
            "percent": null
        },
        {
            "name": "Johnson syndrome",
            "percent": null
        },
        {
            "name": "Additional adverse reactions reported with systemic aminoglycosides include neurotoxicity",
            "percent": null
        },
        {
            "name": "ototoxicity and nephrotoxicity have occurred in patients receiving systemic aminoglycoside therapy",
            "percent": null
        },
        {
            "name": "Aminoglycosides may aggravate muscle weakness in patients with known or suspected neuromuscular disorders",
            "percent": null
        },
        {
            "name": "such as myasthenia gravis or Parkinson",
            "percent": null
        },
        {
            "name": "s disease",
            "percent": null
        },
        {
            "name": "because of their potential effect on neuromuscular function",
            "percent": null
        }
    ]
}